文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

采用系统药理学策略探讨半夏泻心汤治疗肠易激综合征的多成分协同作用机制。

Exploring the multicomponent synergy mechanism of Banxia Xiexin Decoction on irritable bowel syndrome by a systems pharmacology strategy.

机构信息

College of Life Sciences, Nanjing Normal University, Nanjing 210023, China.

出版信息

J Ethnopharmacol. 2019 Apr 6;233:158-168. doi: 10.1016/j.jep.2018.12.033. Epub 2018 Dec 24.


DOI:10.1016/j.jep.2018.12.033
PMID:30590198
Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Banxia Xiexin Decoction (BXD) is a representative prescription to regulate spleen and stomach in "Treatise on Febrile Diseases", which has been proven effective for the clinical treatment of irritable bowel syndrome (IBS) in the past decades. However, the active principles and molecular mechanisms involved in BXD against IBS are vague yet. AIM OF THE STUDY: To unfold multicomponent synergy mechanism of BXD on irritable bowel syndrome, this work explored active principles, drug targets and crucial pathways using a systems pharmacology strategy. MATERIALS AND METHODS: In this study, a systems pharmacology based strategy was applied by the procedures integrating compound database construction, ADME evaluation, target identification, functional annotation, pathway enrichment analysis, network analysis, and molecular docking verification. The 158 compounds from BXD were selected for the screening. The Compound-Target network (C-T) and the Target-Pathway network (T-P) were constructed. The bioinformatics and network topology were employed to systematically reveal multicomponent-target interactions of BXD. The affinity between important ingredients and the kernel targets was validated using molecular mechanics simulation. RESULTS: The 35 potential important ingredients and the 16 associated kernel targets were identified. 27 crucial pathways, in which the kernel targets participated, could regulate the biological processes, such as synthesis of inflammatory mediators, smooth muscle relaxation and synaptic plasticity, closely related to pathological mechanism of IBS. The cross-talk interactions were revealed between TNF signaling pathway, Dopaminergic synapse and cGMP-PKG signaling pathway, which would exert the synergistic influences on the occurrence and treatment of the IBS. PTGS2, CALM, NOS2, SCN5A, and PRSS1 might become novel drug targets for IBS. CONCLUSIONS: The study demonstrated that the synergy molecular mechanisms of BXD mainly involved three therapeutic modules including inhibiting inflammatory reaction, maintaining intestinal function and improving psychological regulation via the multicomponent-target interaction networks. It may also provide the promising drug targets and therapeutic agents for the development of new medicines.

摘要

民族药理学相关性:半夏泻心汤(BXD)是《伤寒论》中调节脾胃的代表性方剂,几十年来已被证明对治疗肠易激综合征(IBS)有效。然而,BXD 治疗 IBS 的活性成分和分子机制尚不清楚。

研究目的:本研究采用系统药理学策略,探索 BXD 治疗肠易激综合征的多成分协同作用机制,研究活性成分、药物靶点和关键途径。

材料和方法:本研究采用系统药理学策略,通过整合化合物数据库构建、ADME 评价、靶点鉴定、功能注释、通路富集分析、网络分析和分子对接验证等程序进行。筛选出 BXD 的 158 种化合物。构建了化合物-靶点网络(C-T)和靶点-通路网络(T-P)。采用生物信息学和网络拓扑学方法系统揭示 BXD 的多成分-靶点相互作用。利用分子力学模拟验证重要成分与核心靶点的亲和力。

结果:确定了 35 种潜在的重要成分和 16 个相关的核心靶点。27 个关键通路,其中核心靶点参与,可调节与 IBS 病理机制密切相关的生物过程,如炎症介质合成、平滑肌松弛和突触可塑性。TNF 信号通路、多巴胺能突触和 cGMP-PKG 信号通路之间存在交叉对话相互作用,对 IBS 的发生和治疗会产生协同影响。PTGS2、CALM、NOS2、SCN5A 和 PRSS1 可能成为 IBS 的新药物靶点。

结论:研究表明,BXD 的协同作用机制主要涉及三个治疗模块,包括抑制炎症反应、维持肠道功能和改善心理调节,通过多成分-靶点相互作用网络发挥作用。它还可能为新药的开发提供有前途的药物靶点和治疗剂。

相似文献

[1]
Exploring the multicomponent synergy mechanism of Banxia Xiexin Decoction on irritable bowel syndrome by a systems pharmacology strategy.

J Ethnopharmacol. 2018-12-24

[2]
Deciphering the multicomponent synergy mechanisms of SiNiSan prescription on irritable bowel syndrome using a bioinformatics/network topology based strategy.

Phytomedicine. 2019-6-4

[3]
Using ultra-performance liquid chromatography with linear ion trap-electrostatic field orbitrap mass spectrometry, network pharmacology, and molecular docking to explore the constituent targets and action mechanisms of decoction of Angelica sinensis, Zingiberis Rhizoma Recens, and Mutton in the treatment of diarrhea-predominant irritable bowel syndrome.

J Pharm Pharmacol. 2024-5-3

[4]
Deciphering the synergistic network regulation of active components from SiNiSan against irritable bowel syndrome via a comprehensive strategy: Combined effects of synephrine, paeoniflorin and naringin.

Phytomedicine. 2021-6

[5]
Identifying the active compounds and mechanism of action of Banxia Xiexin decoction for treating ethanol-induced chronic gastritis using network pharmacology combined with UPLC-LTQ-Orbitrap MS.

Comput Biol Chem. 2021-8

[6]
[Potential molecular mechanism of Banxia Xiexin Decoction in treatment of colon cancer based on network pharmacology and molecular docking technology].

Zhongguo Zhong Yao Za Zhi. 2020-12

[7]
The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies.

J Ethnopharmacol. 2021-7-15

[8]
Exploring the therapeutic mechanism of Banxia Xiexin Decoction in mild cognitive impairment and diabetes mellitus: a network pharmacology approach.

Metab Brain Dis. 2023-10

[9]
Exploration of the potential mechanism of Banxia Xiexin Decoction for the effects on TNBS-induced ulcerative colitis rats with the assistance of network pharmacology analysis.

J Ethnopharmacol. 2021-9-15

[10]
Analysis of the pharmacological mechanism of Banxia Xiexin decoction in treating depression and ulcerative colitis based on a biological network module.

BMC Complement Med Ther. 2020-6-29

引用本文的文献

[1]
Tongxinluo alleviates myocardial ischemia-reperfusion injury by inhibiting the pyroptosis of endothelial cells via the NLRP3/Caspase-1/GSDMD signaling pathway.

J Mol Histol. 2025-9-8

[2]
Silymarin induces multiple myeloma cell apoptosis by inhibiting the JAK2/STAT3 signaling pathway.

Oncol Lett. 2025-7-4

[3]
Exploring the mechanism of proteinuria reduction by hydroxychloroquine in IgA nephropathy using network pharmacology and molecular mocking.

Sci Rep. 2025-7-1

[4]
Evaluating the Mechanism Underlying Multi-Compound Synergy of Banxia Decoction in the Treatment of Hashimoto's Thyroiditis Based on Network Pharmacology and Molecular Docking.

Int J Gen Med. 2025-4-2

[5]
Reunderstanding the classical prescription Banxia Xiexin Decoction: new perspectives from a comprehensive review of clinical research and pharmacological studies.

Chin Med. 2025-3-18

[6]
Network Pharmacology and Experimental Validation of the Therapeutic Effect of Baji Capsule on LPS-Induced Osteoporosis.

Orthop Res Rev. 2025-2-11

[7]
Bioinformatic Analysis and Molecular Docking Identify Isorhamnetin Is a Candidate Compound in the Treatment of Pulmonary Artery Hypertension.

Anatol J Cardiol. 2025-11-28

[8]
water extract Mitigates Age-Associated Physiological Decline in Mice.

Redox Rep. 2024-12

[9]
Traditional Banxia Xiexin decoction inhibits invasion, metastasis, and epithelial mesenchymal transition in gastric cancer by reducing lncRNA TUC338 expression.

Heliyon. 2023-10-20

[10]
Protective Application of Chinese Herbal Compounds and Formulae in Intestinal Inflammation in Humans and Animals.

Molecules. 2023-9-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索